|
SUV39H2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.484200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.582200E-03 |
| Normal-vs-Stage2 |
1.581630E-01 |
| Normal-vs-Stage3 |
5.273600E-01 |
| Normal-vs-Stage4 |
6.102600E-01 |
| Stage1-vs-Stage2 |
6.674200E-01 |
| Stage1-vs-Stage3 |
5.550200E-02 |
| Stage1-vs-Stage4 |
8.285900E-02 |
| Stage2-vs-Stage3 |
1.606790E-01 |
| Stage2-vs-Stage4 |
1.940630E-01 |
| Stage3-vs-Stage4 |
9.670800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.261000E-03 |
| Normal-vs-AfricanAmerican |
5.501400E-01 |
| Normal-vs-Asian |
4.319200E-01 |
| Caucasian-vs-AfricanAmerican |
4.507200E-01 |
| Caucasian-vs-Asian |
1.131440E-01 |
| AfricanAmerican-vs-Asian |
3.748400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.152200E-04 |
| Normal-vs-Female |
1.111630E-01 |
| Male-vs-Female |
3.821000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.608500E-02 |
| Normal-vs-Extreme_Weight |
1.025240E-04 |
| Normal-vs-Obese |
1.841610E-01 |
| Normal-vs-Extreme_Obese |
9.667700E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.462800E-01 |
| Normal_Weight-vs-Obese |
4.551400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.732600E-01 |
| Extreme_Weight-vs-Obese |
4.662300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.089800E-01 |
| Obese-vs-Extreme_Obese |
4.332800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.287800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.610000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.645400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.53899999913543E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.520780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.520990E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.766000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.375870E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.73663999999407E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.725000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.638330E-03 |
| Normal-VS-Type2 PRCC |
1.476150E-01 |
| Normal-VS-KIRP CIMP |
3.722000E-02 |
| Normal-VS-Unclassified PRCC |
2.868200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.134600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.370100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.516600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.677200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.261600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.721000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.698100E-03 |
| Normal-vs-N1 |
4.488400E-02 |
| Normal-vs-N2 |
8.969200E-01 |
| N0-vs-N1 |
6.562900E-03 |
| N0-vs-N2 |
6.090400E-01 |
| N1-vs-N2 |
4.862800E-01 |
|
|
